The institutional landscape for Sana Biotechnology, Inc. (NASDAQ:SANA) includes 136 filers as of the latest reporting cycle ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 14,223,527 | 2,997,391 | 26.70% | $57,889,754.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 10,455,195 | 1,326,222 | 14.53% | $42,552,645.00 |
| STATE STREET CORP | 31 Dec, 2025 | 8,054,841 | 1,374,300 | 20.57% | $32,783,203.00 |
| BAILLIE GIFFORD & CO | 31 Dec, 2025 | 6,609,065 | -4,827,438 | -42.21% | $26,898,895.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 4,118,138 | 694,606 | 20.29% | $16,763,171.00 |
| Marex Group plc | 31 Dec, 2025 | 3,732,780 | -90,000 | -2.35% | $15,192,415.00 |
| Alphabet Inc. | 31 Dec, 2025 | 2,812,500 | 0 | 0.00% | $11,446,875.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 1,691,116 | -301,384 | -15.13% | $6,882,842.00 |
| GOLDMAN SACHS GROUP INC | 31 Dec, 2025 | 1,488,377 | 806,285 | 118.21% | $6,057,694.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Dec, 2025 | 1,399,335 | 126,772 | 9.96% | $5,695,293.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 1,285,045 | 408,540 | 46.61% | $5,230,133.00 |
| UBS Group AG | 31 Dec, 2025 | 1,182,958 | -261,028 | -18.08% | $4,814,639.00 |
| JPMORGAN CHASE & CO | 31 Dec, 2025 | 815,455 | -1,319,989 | -61.81% | $3,318,902.00 |
| JANE STREET GROUP, LLC | 31 Dec, 2025 | 686,684 | 437,564 | 175.64% | $2,794,804.00 |
| DEUTSCHE BANK AG\ | 31 Dec, 2025 | 562,312 | 18,999 | 3.50% | $2,288,610.00 |
| BARCLAYS PLC | 31 Dec, 2025 | 509,889 | -15,967 | -3.04% | $2,075,249.00 |
| Bank of New York Mellon Corp | 31 Dec, 2025 | 457,226 | 51,565 | 12.71% | $1,860,912.00 |
| Swiss National Bank | 31 Dec, 2025 | 335,800 | 73,500 | 28.02% | $1,366,706.00 |
| Squarepoint Ops LLC | 31 Dec, 2025 | 331,741 | 109,419 | 49.22% | $1,350,186.00 |
| Nuveen, LLC | 31 Dec, 2025 | 325,212 | 21,183 | 6.97% | $1,323,613.00 |